Novo Integrated Sciences, Inc. (NVOS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.75 Million USD | -46.79% |
| 2022 | 3.3 Million USD | -59.64% |
| 2021 | 8.18 Million USD | 154.43% |
| 2020 | 3.21 Million USD | -13.04% |
| 2019 | 3.7 Million USD | 202.42% |
| 2018 | 1.22 Million USD | -77.86% |
| 2017 | 5.52 Million USD | 47643.33% |
| 2016 | 11.58 Thousand USD | -99.76% |
| 2015 | 4.84 Million USD | 1474.0% |
| 2014 | 307.59 Thousand USD | 156.46% |
| 2013 | 119.94 Thousand USD | 3500.75% |
| 2012 | 3331.00 USD | -51.73% |
| 2011 | 6901.00 USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 86.00 USD | -99.83% |
| 2008 | 49.45 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 250 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 63.57 Thousand USD | -96.27% |
| 2024 Q1 | 1.64 Million USD | -1.94% |
| 2024 Q2 | 1.7 Million USD | 2570.88% |
| 2023 Q2 | 1.95 Million USD | -36.83% |
| 2023 Q1 | 3.09 Million USD | -6.33% |
| 2023 FY | 1.75 Million USD | -46.79% |
| 2023 Q3 | 1.85 Million USD | -5.3% |
| 2023 Q4 | 1.75 Million USD | -5.04% |
| 2022 Q2 | 12.75 Million USD | 307.04% |
| 2022 Q4 | 3.3 Million USD | -74.84% |
| 2022 FY | 3.3 Million USD | -59.64% |
| 2022 Q1 | 3.13 Million USD | -61.74% |
| 2022 Q3 | 13.13 Million USD | 2.98% |
| 2021 FY | 8.18 Million USD | 154.43% |
| 2021 Q3 | 2.09 Million USD | 1.47% |
| 2021 Q4 | 8.18 Million USD | 291.15% |
| 2021 Q1 | 3.09 Million USD | -3.93% |
| 2021 Q2 | 2.06 Million USD | -33.27% |
| 2020 Q2 | 3.67 Million USD | 2.66% |
| 2020 Q4 | 3.21 Million USD | -6.53% |
| 2020 FY | 3.21 Million USD | -13.04% |
| 2020 Q3 | 3.44 Million USD | -6.35% |
| 2020 Q1 | 3.58 Million USD | -3.23% |
| 2019 FY | 3.7 Million USD | 202.42% |
| 2019 Q1 | 1.2 Million USD | -1.57% |
| 2019 Q2 | 1.21 Million USD | 0.92% |
| 2019 Q3 | 1.78 Million USD | 47.21% |
| 2019 Q4 | 3.7 Million USD | 106.82% |
| 2018 Q4 | 1.22 Million USD | -25.1% |
| 2018 Q3 | 1.63 Million USD | -1.23% |
| 2018 Q2 | 1.65 Million USD | -69.2% |
| 2018 Q1 | 5.37 Million USD | -2.85% |
| 2018 FY | 1.22 Million USD | -77.86% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q4 | 5.52 Million USD | 1386.22% |
| 2017 Q3 | 371.99 Thousand USD | 4458.23% |
| 2017 Q2 | 8161.00 USD | 0.0% |
| 2017 FY | 5.52 Million USD | 47643.33% |
| 2016 FY | 11.58 Thousand USD | -99.76% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 11.58 Thousand USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | 4.84 Million USD | 1474.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | 307.59 Thousand USD | 12.82% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 FY | 307.59 Thousand USD | 156.46% |
| 2014 Q3 | 247.16 Thousand USD | 26.43% |
| 2014 Q1 | 119.94 Thousand USD | -73.32% |
| 2014 Q4 | 272.64 Thousand USD | 10.31% |
| 2014 Q2 | 195.49 Thousand USD | 63.0% |
| 2013 FY | 119.94 Thousand USD | 3500.75% |
| 2013 Q4 | 449.57 Thousand USD | 13396.76% |
| 2013 Q3 | 3331.00 USD | -94.1% |
| 2013 Q2 | 56.48 Thousand USD | 1595.59% |
| 2013 Q1 | 3331.00 USD | 0.0% |
| 2012 Q4 | 3331.00 USD | 0.0% |
| 2012 Q2 | 4631.00 USD | -32.89% |
| 2012 Q1 | 6901.00 USD | 0.0% |
| 2012 FY | 3331.00 USD | -51.73% |
| 2012 Q3 | - USD | -100.0% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 21.57 Thousand USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q3 | 1901.00 USD | -91.19% |
| 2011 FY | 6901.00 USD | 0.0% |
| 2010 Q1 | 86.00 USD | -95.48% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | 33.53 Thousand USD | -15.51% |
| 2010 Q3 | 39.68 Thousand USD | 207.49% |
| 2010 Q2 | 12.9 Thousand USD | 14908.14% |
| 2009 Q4 | 1901.00 USD | -29.72% |
| 2009 FY | 86.00 USD | -99.83% |
| 2009 Q1 | 49.45 Thousand USD | -37.27% |
| 2009 Q2 | 57.44 Thousand USD | 16.16% |
| 2009 Q3 | 2705.00 USD | -95.29% |
| 2008 Q4 | 78.84 Thousand USD | 1.99% |
| 2008 Q1 | - USD | -100.0% |
| 2008 Q2 | 1901.00 USD | 0.0% |
| 2008 FY | 49.45 Thousand USD | 0.0% |
| 2008 Q3 | 77.3 Thousand USD | 3966.54% |
| 2007 Q2 | 1901.00 USD | 0.0% |
| 2007 Q4 | 1901.00 USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 Q3 | 1901.00 USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | 1901.00 USD | 0.0% |
| 2006 Q3 | 1901.00 USD | 0.0% |
| 2006 Q2 | 1901.00 USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | 250 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Oncology Network, Inc. | 120.44 Million USD | 98.54% |
| ATI Physical Therapy, Inc. | 513.04 Million USD | 99.657% |
| Assure Holdings Corp. | 505 Thousand USD | -248.241% |
| Panamera Holdings Corporation | - USD | -Infinity% |